Skip to main content
. 2021 Oct 8;41(11):975–988. doi: 10.1007/s40261-021-01085-8
Vaccination of the population aged 60 years and older against COVID-19 is a cost-effective strategy compared with other strategies in the Danish vaccination programme.
Whether the vaccination programme against COVID-19 for the population younger than 60 years old is cost-effective depends on the price of the vaccine and the costs of its administration as well as the testing costs.